This article reviews the role of minimal residual disease (MRD) testing in multiple myeloma (MM), highlighting its association with improved progression-free survival and overall survival.

Read More> https://multiplemyeloma.pocn.com/diagnosis/advances-in-mrd-testing-for-multiple-myeloma-impact-on-prognosis-and-treatment-decisions/